Recent Quotes
My Watchlist
Indicators
Star 60
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Hldgs Inc (NY: DNA )

0.4497 -0.0123 (-2.66%)
Official Closing Price Updated: 7:00 PM EDT, Jun 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 41,236,984
Open 0.4620
Bid (Size) 0.4510 (224)
Ask (Size) 0.4530 (20)
Prev. Close 0.4620
Today's Range 0.4226 - 0.4700
52wk Range 0.4226 - 2.545
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
These pharma and biotech players could become long-term winners. 
Via The Motley Fool
3 Sorry Biotech Stocks to Sell in May While You Still Can
Morgan Stanley's bullish outlook highlights the need for strategic trimming of underperforming biotech stocks to sell. 
Via InvestorPlace

Performance

YTD
-73.07%
-73.07%
1 Month
-46.40%
-46.40%
3 Month
-58.74%
-58.74%
6 Month
-71.54%
-71.54%
1 Year
-76.33%
-76.33%

More News

Read More
Ginkgo Bioworks Stock: Bull vs. Bear
Via The Motley Fool
Should You Buy the Dip on Ginkgo Bioworks Stock?
Via The Motley Fool
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk
Via The Motley Fool
Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF
Via Benzinga
Topics ETFs
3 Things You Need to Know if You Buy Ginkgo Bioworks Today
Via The Motley Fool
How Is The Market Feeling About Ginkgo Bioworks Holdings?
Via Benzinga
Down 72%. Is Ginkgo Bioworks a Buy on the Dip?
Via The Motley Fool
Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst
Via The Motley Fool
Investment Advisor Says 'Throwing Random Darts At Tickers' Would Beat ARKK As Cathie Wood's Flagship Fund Lags Far Behind Soaring Market: 'How Do They Do It?!'
Via Benzinga
Topics ETFs Stocks
Exposures US Equities
Is Ginkgo Bioworks Holdings Stock a Buy?
Via The Motley Fool
4 Small-Cap Value Stocks That Could Go Parabolic
Via The Motley Fool
Ginkgo Bioworks: Buy, Sell, or Hold?
Via The Motley Fool
What's the Difference Between Biotech Stocks and TechBio Stocks?
Via The Motley Fool
TeraWulf Posts Weak Results, Joins StoneCo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Akamai Technologies Issues Weak Outlook, Joins Applied Optoelectronics, JFrog And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
DNA Stock Earnings: Ginkgo Bioworks Holdings Meets EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Ginkgo Bioworks Stock Falls On Disappointing Q1 Sales: 'This Trend Needs To Change'
Via Benzinga
3 Meme Stocks to Sell in May Before They Crash & Burn
Via InvestorPlace
Want $10,000? Invest $1,000 in These 3 Penny Stocks Now
Via InvestorPlace
Why Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today?
Via InvestorPlace
Is a Giant Short Squeeze in Ginkgo Bioworks (DNA) Stock?
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.